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Self-monitoring of oral anticoagulation therapy in children
Abstract
This study aimed to investigate the accuracy of home International Normalized Ratio (INR)
self-monitoring in pediatric patients on long-term oral anticoagulation therapy. Statistical and clinical
agreement of INR values from capillary whole blood samples measured by 2 different portable
prothrombin time monitors (CoaguChek S and XS) and venous blood samples measured by a laboratory
coagulation analyzer were evaluated using the Bland-Altman analysis. Eighty-three INR comparisons
(56 using the CoaguChek S and 27 using the CoaguChek XS) were obtained from 35 children aged 4
months to 18 years. Mean differences between venous and capillary INR values and their limits of
agreement were -0.04 (-0.63 to 0.55) overall, 0.006 (-0.63 to 0.65) for the CoaguChek S and -0.13 (-0.57
to 0.31) for the CoaguChek XS. The Pearson correlation coefficients were 0.88 overall, 0.84 for the
CoaguChek S and 0.95 for the CoaguChek XS. Expanded and narrow agreements for all patients were
97.6 and 94%, respectively. In conclusion, home INR self-monitoring is accurate for children requiring
long-term oral anticoagulation therapy. Our data suggest that INR self-monitoring with the newer
CoaguChek XS is more accurate than with the older CoaguChek S monitor.
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 Introduction 
 In the last few decades, the number of children requir-
ing oral anticoagulation therapy (OAT) for prevention or 
treatment of thromboembolic events has increased. This 
is partly related to the advances in pediatric cardiac sur-
gery and intensive care in the management of severe 
childhood diseases, in particular complex congenital 
heart diseases, prematurity and cancer  [1, 2] . The vitamin 
K antagonists phenprocoumon, acenocoumarol and war-
farin are the most commonly used oral anticoagulants for 
prolonged outpatient treatment. Close International Nor-
malized Ratio (INR) monitoring is necessary to maintain 
the intensity of OAT at a level capable of preventing both 
thrombotic and bleeding complications.
 Due to the lack of clinical trials, guidelines for antico-
agulation treatment as well as current therapeutic INR 
ranges in children are widely extrapolated from recom-
mendations for adults  [2] . However, for several reasons, 
management of OAT in children is more difficult and re-
quires more frequent monitoring compared with the 
adult experience. Rapid INR fluctuations due to intercur-
rent illnesses, variation in medication and changes in diet 
occur more often than in adults  [3] . Venous blood sam-
pling is mostly unpleasant and painful for children and 
can be technically demanding, especially in those chil-
dren with poor venous access. Thus, capillary INR mon-
itoring potentially offers advantages to children on long-
term OAT.
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 Abstract 
 This study aimed to investigate the accuracy of home Inter-
national Normalized Ratio (INR) self-monitoring in pediatric 
patients on long-term oral anticoagulation therapy. Statisti-
cal and clinical agreement of INR values from capillary whole 
blood samples measured by 2 different portable prothrom-
bin time monitors (CoaguChek S and XS) and venous blood 
samples measured by a laboratory coagulation analyzer 
were evaluated using the Bland-Altman analysis. Eighty-
three INR comparisons (56 using the CoaguChek S and 27 
using the CoaguChek XS) were obtained from 35 children 
aged 4 months to 18 years. Mean differences between ve-
nous and capillary INR values and their limits of agreement 
were –0.04 (–0.63 to 0.55) overall, 0.006 (–0.63 to 0.65) for the 
CoaguChek S and –0.13 (–0.57 to 0.31) for the CoaguChek XS. 
The Pearson correlation coefficients were 0.88 overall, 0.84 
for the CoaguChek S and 0.95 for the CoaguChek XS. Ex-
panded and narrow agreements for all patients were 97.6 
and 94%, respectively. In conclusion, home INR self-monitor-
ing is accurate for children requiring long-term oral antico-
agulation therapy. Our data suggest that INR self-monitor-
ing with the newer CoaguChek XS is more accurate than with 
the older CoaguChek S monitor. 
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 In the 1980s, portable prothrombin time (PT) moni-
tors using capillary whole blood and providing an INR 
result within minutes have been introduced to allow pa-
tients to monitor OAT by themselves. The successful use 
of these devices in adults has been demonstrated in sev-
eral large studies showing very good correlations between 
venous and capillary INRs and indicating that the qual-
ity of OAT is even better than with conventional manage-
ment  [4–9] .
 Unfortunately, only few studies evaluating capillary 
INR monitoring in children have been conducted so far 
 [10–16] . In particular, very few pediatric data are avail-
able on the newer PT monitor, CoaguChek XS. This study 
aims to investigate the accuracy of home INR self-moni-
toring in pediatric patients on long-term OAT, compar-
ing the newer CoaguChek XS with the older CoaguChek 
S monitor.
 Patients and Methods 
 Patient Population 
 Since 2002, pediatric patients on long-term OAT with phen-
procoumon followed at the University Children’s Hospital of Zu-
rich, Switzerland, and/or their parents have been offered the pos-
sibility of self-monitoring oral anticoagulation at home using a 
portable PT monitor. All patients, who have been willing to per-
form home INR self-monitoring, constitute the cohort for this 
study, without exclusions.
 To be able to perform home INR self-monitoring, all patients 
and/or parents were educated and trained by a specialized team 
consisting of a physician and a pediatric nurse. The training pro-
gram involved theoretical aspects of OAT (interpretation of home 
INR results, dosing and dose adjustment, interaction with other 
medication, influence of nutrition and intercurrent illnesses, as 
well as documentation of home INR results and adverse effects), 
and repeated practical demonstrations on the use of the portable 
PT monitor. Patients and/or parents were given the possibility to 
contact the team at any time when home INR values were outside 
the target range, or by uncertainties. On a regular basis, home INR 
records were discussed with the patients and/or parents, and a 
comparison between capillary and venous INR was performed.
 Patient characteristics including sex, age, indication for OAT, 
INR target ranges and documented home INR values were col-
lected from the medical records. This study was approved by the 
Research Ethics Boards of the University Children’s Hospital, Zu-
rich, Switzerland. 
 Portable PT Monitor 
 All patients used the portable PT monitor CoaguChek S or XS 
(Roche Diagnostics, Rotkreuz, Switzerland), depending on when 
they started OAT. Both are capillary whole blood, battery-pow-
ered analyzers functioning with single used, thromboplastin-
coated test strips to activate the coagulation cascade. For the de-
termination of the PT, the CoaguChek S uses rabbit brain throm-
boplastin [International Sensitivity Index (ISI) 1.6–1.8] and a 
photometric method, whereas the CoaguChek XS uses recombi-
nant human thromboplastin (ISI value close to 1) and an ampero-
metric (electrochemical) method.
 Blood Collection and PT Measurements 
 Capillary whole blood samples were obtained by fingertip 
puncture using an Accu-Chek Softclix Pro lancet system (Roche 
Diagnostics). One drop of at least 10   l capillary blood was di-
rectly applied on the test strip, which was already inserted into the 
portable PT monitor.
 Venous blood samples were drawn by venipuncture into 1.4-
ml plastic tubes in the proportion of 9 parts blood to 1 part 0.106 
mol/l sodium citrate for a final sodium citrate concentration of 
10.6 mmol/l. Venous citrated blood was analyzed in the labora-
tory at our institution after centrifugation at 3,000  g for 15 min at 
18 ° C on a STA Compact coagulation analyzer (Roche Diagnos-
tics). Between 2002 and 2007, the thromboplastin used by the lab-
oratory was Neoplastin Plus (thromboplastin 1), ISI 1.3 (Roche 
Diagnostics). Since 2007, a new thromboplastin, Neoplastin R 
(thromboplastin 2), with an ISI close to 1, has been used (Roche 
Diagnostics). The manufacturer’s ISIs and mean normal PT were 
used to determine venous INR values.
 The PT values from both capillary whole blood samples mea-
sured by the portable PT monitor and venous blood samples mea-
sured by the laboratory coagulation analyzer were expressed in 
INR units according to the recommendations given by the Inter-
national Committee of Standardization in Hematology in 1985 
and by the World Health Organization.
 INR Comparisons 
 Comparisons between venous and capillary INR were per-
formed 1–2 times per year for each patient. The time between the 
venous and capillary blood collection did not exceed 15 min.
 Clinically relevant agreement was defined based on whether 
or not the difference between venous and capillary INR measure-
ments would be likely to influence clinical management of OAT. 
Two types of clinical agreement were used. Expanded agreement 
was achieved if both INR values were either within, above or be-
low the target therapeutic range, or if 1 of the 2 INR values was 
within the therapeutic range and the pair within 0.5 INR units. 
Narrow agreement was achieved if both INR values were within 
0.5 INR units  [17] .
 Statistical Analysis 
 The proportion of home INR values falling within the thera-
peutic range was assessed for each patient from the collected data, 
and the mean and its 95% confidence interval (CI) were calculated 
in order to determine the time in therapeutic range. Agreement 
between venous and capillary INR values was analyzed using a 
Bland-Altman plot. The mean difference between venous and cap-
illary INR was calculated for overall comparisons and for compar-
isons before and after changing the laboratory thromboplastin in 
order to asses the limits of agreement (mean difference  8 1.96 
times the standard deviation)  [18] . Significant mean differences of 
venous and capillary INR were tested by the Mann-Whitney test. 
A p value  ! 0.05 was considered significant. In addition, the corre-
lation between venous and capillary INR was determined using the 
Pearson correlation coefficient. Analysis was performed using Mi-
crosoft Excel 2004, version 11.3.5, and GraphPad InStat for Win-
dows (GraphPad Software, San Diego, Calif., USA; version 3.05).
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 Results 
 Patient Population 
 Between 2002 and 2008, 35 pediatric patients received 
a portable PT monitor for a total of 89 self-monitoring 
years (range 2 months to 6 years). Demographic and clin-
ical characteristics of patients are depicted in  table 1 . Of 
the 35 patients, 23 received a CoaguChek S and 12 a Coa-
guChek XS monitor. Two of 23 patients were switched to 
the CoaguChek XS monitor for no particular reason after 
6 and 12 months, respectively.
 Capillary INR Measurements 
 During the study period, a median of 3.3 capillary INR 
measurements per month was performed by the 35 pa-
tients for a total of 3,706 capillary INR measurements. In 
70.1% (95% CI 65.4–74.8), capillary INR measurements 
were within, in 13.6% (95% CI 10.3–16.8) above and in 
16.4% (95% CI 12.8–19.9) below individual INR target 
ranges.
 INR Comparisons 
 Thirty-three of the 35 patients had 1 or more INR 
comparison measurements for a total of 83 comparison 
values. Of the 83 capillary INR measurements for com-
parison, 56 were performed using the CoaguChek S and 
27 using the CoaguChek XS. 
 For all comparisons, mean differences between ve-
nous and capillary INR values and their limits of agree-
ment were –0.04 (–0.63 to 0.55) overall, 0.006 (–0.63 to 
0.65) for the CoaguChek S group and –0.13 (–0.57 to 0.31) 
for the CoaguChek XS group (p = 0.02). The Pearson cor-
relation coefficients were 0.88 overall, 0.84 for the Coa-
guChek S group and 0.95 for the CoaguChek XS group. 
Overall expanded and narrow agreements were 97.6 and 
94%, respectively.
 Mean differences between venous and capillary INR 
values, their limits of agreement and the expanded and 
narrow agreements before and after changing the labora-
tory thromboplastin are summarized in  table 2 . While 
the CoaguChek S showed narrower limits of agreements 
after changing the thromboplastin, no differences were 
Table 1. Characteristics of 35 pediatric patients
Characteristics 
Sex, n
Male 23
Female 12
Age, years
Mean 9.2
Range 0.4–18.5
Median 8.1
Indication for oral anticoagulation, n
Primary pulmonary arterial hypertension 6
Congenital heart disease 19
Prosthetic aortic or mitral valve 7
Secondary pulmonary arterial hypertension 5
Disturbances of rate and rhythm 4
Fontan circulation 3
Dilated cardiomyopathy 4
History of repeated thrombosis 3
Giant aneurysm after Kawasaki disease 3
INR target range, n
1.5–2.5 11
2–3 19
2.5–3.5 5
Duration of self-monitoring, years
Mean 2.5 
Range 0.2–6
Median 2
Table 2. INR comparisons before (thromboplastin 1) and after (thromboplastin 2) changing the laboratory thromboplastin
CoaguChek Thromboplastin 1 Thromboplastin 2
mean difference 
venous-capillary INR
limits of 
agreement
expanded/narrow 
agreement, %
mean difference 
venous-capillary INR
limits of 
agreement
expanded/narrow 
agreement, %
S 0.067a, b –0.59 to 0.72 94/92 –0.105a –0.67 to 0.47 100/95
XS –0.13b –0.58 to 0.32 100/100 –0.14 –0.58 to 0.31 100/93
a p = 0.03, significant mean differences of venous and capillary INR before and after changing the laboratory thromboplastin. 
b p = 0.02, significant mean differences of venous and capillary INR between the CoaguChek S and XS.
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observed for the CoaguChek XS before and after chang-
ing the thromboplastin. The corresponding Bland-Alt-
man plots of the differences between venous and capil-
lary INR values plotted against their means before and 
after changing the thromboplastin are shown in  figures 
1 and  2 . The Pearson correlation coefficients before 
changing the thromboplastin were 0.84 for the Coagu-
Chek S and 0.95 for the CoaguChek XS. The Pearson cor-
relation coefficients after changing the thromboplastin 
were 0.87 for the CoaguChek S and 0.93 for the Coagu-
Chek XS.
 Discussion 
 Only few studies evaluating self-monitoring of OAT in 
pediatric patients have been conducted so far. The aim of 
this study was to assess the statistical and clinical agree-
ment between capillary INRs measured by 2 portable
PT monitors and venous INRs measured by a standard 
laboratory method in children. The results of this study 
validate home INR self-monitoring to be accurate for 
children on long-term OAT, especially when the newer 
CoaguChek XS monitor is used.
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 Fig. 1. Bland-Altman plots showing the differences between capil-
lary (INR cap) and venous (INR ven) INR values plotted against 
their means for INR comparisons with capillary INR performed 
using the CoaguChek S (n = 36) ( a ) and  comparisons with capil-
lary INR performed using the CoaguChek XS (n = 13) ( b ) before 
changing the laboratory thromboplastin (thromboplastin 1). The 
straight line indicates the mean difference between capillary and 
venous INR values, while the dashed lines indicate their limits of 
agreement (mean difference  8 1.96 times the standard devia-
tion). 
 Fig. 2. Bland-Altman plots showing the differences between cap-
illary (INR cap) and venous (INR ven) INR values plotted against 
their means for INR comparisons with capillary INR performed 
using the CoaguChek S (n = 20) ( a ) and  comparisons with capil-
lary INR performed using the CoaguChek XS (n = 14) ( b ) after 
changing the laboratory thromboplastin (thromboplastin 2). The 
straight line indicates the mean difference between capillary and 
venous INR values, while the dashed lines indicate their limits of 
agreement (mean difference  8 1.96 times the standard devia-
tion). 
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 The challenges associated with the management of 
OAT in children require more frequent INR measure-
ments and dose adjustments compared with adults. The 
use of a portable PT monitor, which measures thrombo-
plastin-mediated clotting times using capillary whole 
blood, allows rapid testing at the patient’s convenience as 
well as prompt attention to critical values and drug dos-
age adjustment. A more rapid correction of out-of-range 
INR values may play a critical role in reducing the inci-
dence of thrombotic and hemorrhagic complications 
during OAT, particularly in children  [3] . However, for 
this purpose, a high grade of accuracy of the portable PT 
monitor needs to be demonstrated.
 In the present study, the overall average difference be-
tween venous and capillary INR results was –0.04 INR 
units. Almost all previous studies evaluating portable PT 
monitors in children have used correlation coefficients to 
assess the correlation between venous and capillary INR 
measurements. However, correlation coefficients mea-
sure the strength of a relation between 2 variables, not the 
agreement between them. Thus, high correlations for 2 
given methods do not mean that the 2 methods agree  [18] . 
Besides very few other small reports, only our study and 
the one by Baumann et al.  [10] have assessed agreement 
between venous and capillary INR measurements in a 
substantial number of children using the Bland-Altman 
analysis. While both studies indicate that capillary INR 
measurements using the portable PT monitor are very 
accurate, the negative values in our study show that the 
capillary INR was on average lower than the venous INR. 
As far as the negative mean difference measured for the 
CoaguChek XS is concerned, our findings indicating an 
underestimation of capillary INRs are consistent with re-
sults of previous studies in adults  [19] .
 One important clinical issue when comparing 2 meth-
ods of measurement is whether or not the difference be-
tween the 2 methods would likely influence the clinical 
management. In this study, the overall expanded and 
narrow agreements were 97.6 and 94%, respectively, indi-
cating that the differences between capillary and venous 
INRs were not sufficient to change clinical management 
decisions.
 In 2006, the CoaguChek S monitor was replaced by the 
new generation of portable PT monitors, the CoaguChek 
XS. This new monitor offers several innovative practical 
and technical features, including smaller size and weight, 
side and top blood dosing options, the use of a recombi-
nant human thromboplastin with a lower ISI, and inter-
nal quality control included on the test strip. Recent data 
from an ongoing study in 16 pediatric patients have sug-
gested that the CoaguChek XS may be less accurate than 
the CoaguChek S monitor  [20] . By contrast, the Coagu-
Chek XS in our study showed an increased correlation 
coefficient and narrower limits of agreement as com-
pared with the CoaguChek S, suggesting increased accu-
racy. Our results also indicate that, when using the Coa-
guChek XS, INR agreements are not dependent on the 
type of thromboplastin used by the laboratory. This 
seems not to be the case when the CoaguChek S is used. 
The inferior number of children using the CoaguChek 
XS compared with the number of children using the Co-
aguChek S monitor may limit the interpretation of our 
study results. However, our findings are consistent with 
results of recent studies in adults, also showing that the 
newer CoaguChek XS is more precise and accurate than 
the older CoaguChek S monitor  [21–23] . Our results are 
also consistent with the results of another recent pediat-
ric study showing a much more satisfactory performance 
of the CoaguChek XS compared with the CoaguChek S 
 [16] . However, in this study, laboratory INR measure-
ments were performed not on venous but on capillary 
specimens, which may potentially influence compari-
sons of INR results  [16] .
 In conclusion, results of this study show a very good 
agreement between venous and capillary INR measure-
ments. Portable PT monitors provide an accurate and 
simple method for home INR self-monitoring of long-
term OAT in children, in particular when the newer Co-
aguChek XS monitor is used. 
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